Clinical Trial Update: 68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC. [Phase 2]

View source ↗

Summary

Phase 2 trial update for 68Ga-NY104 PET/CT guided radiation therapy in clear cell renal cell carcinoma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• 68Ga-NY104 (Gallium-68 NY104 PET tracer)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Clear Cell Renal Cell Carcinoma | Phase 2 | Status: RECRUITING